MUMBAI, Dec 1 (Reuters) - Indian drug maker Cipla Ltd (CIPL.BO) is in talks with a host of global drug makers, including Pfizer Inc (PFE.N), to supply generic products, Joint Managing Director Amar Lulla said on Tuesday.
“Yes, we are talking to some companies,” Lulla said. “Nothing has been signed yet.”
He declined to give a timeline when a deal would be announced or a forecast for the revenue expectation from such a deal.
Global drug makers are increasingly looking to low-cost destinations like India to tie up supplies as they battle falling prices and increasing generic competition. (Reporting by Bharghavi Nagaraju; Editing by Ranjit Gangadharan) ((email@example.com; +91 22 6636 9059; Reuters Messaging: firstname.lastname@example.org)) (If you have a query or comment on this story, send an email to email@example.com)